arginine has been researched along with Malignant Mesothelioma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, SE; Butt, Z; Coulson, JM; Goate, Z; Grosman, R; Jackson, R; Kenyani, J; Lian, LY; Marciniak, SJ; Querques, F; Rassl, DM; Sacco, JJ; Shaw, L; Silva, LC; Szlosarek, PW; Tripari, M | 1 |
| Allen, M; Balkwill, F; Berry, JS; Bomalaski, J; Carpentier, J; Chelala, C; Cutts, R; Feng, S; Ghazaly, E; Hallden, G; Nattress, C; Pavlyk, I; Phillips, MM; Sheaff, M; Steele, J; Szlosarek, PW | 1 |
| Angelico, G; Broggi, G; Caltabiano, R; Filetti, V; Ledda, C; Lombardo, C; Loreto, C; Rapisarda, V; Vitale, E | 1 |
| Chelala, C; Freitas, MO; Ghazaly, E; Lattanzio, L; Lo Nigro, C; Locke, M; Martin, SA; Mitsinga, M; Nagano, A; Szlosarek, P; Wang, J | 1 |
| Avril, NE; Beck, S; Bomalaski, JS; Butcher, L; Crook, T; Dancey, G; Ellis, S; Fennell, D; Gilligan, D; Hackshaw, A; Hillman, P; Johnston, A; Lawrence, C; Lemoine, N; Lind, M; Luong, P; Mitra, S; Nolan, L; Payne, S; Phillips, MM; Rudd, RM; Schmid, P; Shamash, J; Sheaff, MT; Spicer, J; Steele, JP; Szlosarek, PW; Szyszko, T; Taylor, P; Thomson, J; Tomsa, M; Wu, BW | 1 |
1 trial(s) available for arginine and Malignant Mesothelioma
| Article | Year |
|---|---|
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Arginine; Argininosuccinate Synthase; Biomarkers, Tumor; Citrullinemia; Disease-Free Survival; DNA Methylation; Endpoint Determination; Female; Humans; Hydrolases; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Polyethylene Glycols; Treatment Outcome | 2017 |
4 other study(ies) available for arginine and Malignant Mesothelioma
| Article | Year |
|---|---|
BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification.
Topics: Amino Acids; Arginine; Argininosuccinate Synthase; Cell Line, Tumor; Humans; Mesothelioma; Mesothelioma, Malignant; Tumor Suppressor Proteins; Ubiquitin Thiolesterase | 2023 |
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma.
Topics: Animals; Arginine; Argininosuccinate Synthase; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Macrophages; Mesothelioma; Mesothelioma, Malignant; Mice; Neoplasm Recurrence, Local; Polyethylene Glycols; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2023 |
Immunohistochemical Expression of Serine and Arginine-Rich Splicing Factor 1 (SRSF1) in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Study.
Topics: Arginine; Asbestos, Amphibole; Biomarkers, Tumor; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; RNA Splicing Factors; Serine; Serine-Arginine Splicing Factors | 2021 |
Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1.
Topics: Arginine; Argininosuccinate Synthase; Cell Line, Tumor; DNA Methylation; Humans; Hydrolases; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Polyamines; Polyethylene Glycols; Promoter Regions, Genetic | 2016 |